Correction to: Nature Immunology https://doi.org/10.1038/s41590-019-0423-0, published online 1 July 2019.
In the version of this article initially published, the cell conversion was stated incorrectly (‘ILC2s to ILC1-like cells’) in the first sentence of the second paragraph in the second Results subsection; the correct description is ‘ILC1s to ILC2-like cells’. Also, the far left plot in Fig. 1d was missing the vertical axis label; this should be ‘IL-13−APC’. Finally, in the legend to Fig. 3a,b, the human ILCs were identified incorrectly (CD45+CD56‒CD127‒); the correct phenotype is CD45+CD56‒CD127+. The errors have been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Bernink, J.H., Ohne, Y., Teunissen, M.B.M. et al. Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies. Nat Immunol 21, 101 (2020). https://doi.org/10.1038/s41590-019-0554-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-019-0554-3